Convergence Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.61M Buy
29,971
+13,670
+84% +$3.19M 0.72% 37
2026
Q1
$3.98M Buy
16,301
+4,079
+33% +$950K 0.65% 45
2025
Q4
$2.53M Sell
12,222
-250
-2% -$49.4K 0.5% 55
2025
Q3
$2.31M Buy
12,472
+342
+3% +$58.6K 0.52% 56
2025
Q2
$1.85M Sell
12,130
-682
-5% -$105K 0.47% 61
2025
Q1
$2.12M Sell
12,812
-3,379
-21% -$529K 0.59% 44
2024
Q4
$2.34M Buy
16,191
+1,897
+13% +$294K 0.52% 56
2024
Q3
$2.32M Buy
14,294
+483
+3% +$77K 0.62% 46
2024
Q2
$2.02M Buy
13,811
+4,871
+54% +$724K 0.59% 46
2024
Q1
$1.41M Buy
8,940
+2,227
+33% +$354K 0.54% 57
2023
Q4
$1.05M Buy
6,713
+34
+0.5% +$5.21K 0.55% 68
2023
Q3
$1.04M Buy
6,679
+132
+2% +$21.8K 0.62% 60
2023
Q2
$1.08M Sell
6,547
-103
-2% -$16.6K 0.62% 59
2023
Q1
$1.03M Sell
6,650
-262
-4% -$42.3K 0.61% 62
2022
Q4
$1.22M Buy
6,912
+8
+0.1% +$1.38K 0.72% 50
2022
Q3
$1.13M Buy
6,904
+964
+16% +$163K 0.74% 47
2022
Q2
$1.05M Sell
5,940
-1,914
-24% -$341K 0.64% 60
2022
Q1
$1.39M Buy
7,854
+294
+4% +$50K 0.72% 51
2021
Q4
$1.29M Sell
7,560
-372
-5% -$60.9K 0.66% 60
2021
Q3
$1.28M Buy
7,932
+201
+3% +$34.3K 0.69% 54
2021
Q2
$1.27M Sell
7,731
-488
-6% -$80.8K 0.55% 73
2021
Q1
$1.35M Buy
8,219
+374
+5% +$60.5K 0.62% 58
2020
Q4
$1.24M Sell
7,845
-5,143
-40% -$759K 0.62% 59
2020
Q3
$1.93M Sell
12,988
-573
-4% -$84.8K 0.67% 35
2020
Q2
$1.91M Buy
13,561
+1,518
+13% +$221K 0.66% 46
2020
Q1
$1.58M Buy
12,043
+5,327
+79% +$756K 0.69% 44
2019
Q4
$980K Sell
6,716
-64
-0.9% -$8.68K 0.28% 130
2019
Q3
$877K Sell
6,780
-47
-0.7% -$6.19K 0.24% 156
2019
Q2
$951K Sell
6,827
-12,271
-64% -$1.7M 0.23% 159
2019
Q1
$2.67M Buy
19,098
+12,484
+189% +$1.67M 0.58% 49
2018
Q4
$853K Buy
6,614
+653
+11% +$91.1K 0.2% 154
2018
Q3
$824K Buy
5,961
+1,089
+22% +$145K 0.17% 167
2018
Q2
$591K Sell
4,872
-182
-4% -$22.7K 0.08% 253
2018
Q1
$648K Buy
5,054
+400
+9% +$54.1K 0.08% 253
2017
Q4
$650K Buy
4,654
+58
+1% +$8.08K 0.09% 260
2017
Q3
$598K Sell
4,596
-26,052
-85% -$3.45M 0.08% 264
2017
Q2
$4.05M Buy
30,648
+16,734
+120% +$2.13M 0.59% 33
2017
Q1
$1.73M Sell
13,914
-576
-4% -$68.8K 0.24% 156
2016
Q4
$1.67M Buy
14,490
+49
+0.3% +$5.66K 0.23% 173
2016
Q3
$1.71M Buy
14,441
+82
+0.6% +$9.95K 0.25% 147
2016
Q2
$1.74M Sell
14,359
-11,036
-43% -$1.25M 0.24% 158
2016
Q1
$2.75M Sell
25,395
-47,421
-65% -$4.91M 0.33% 107
2015
Q4
$7.48M Sell
72,816
-3,353
-4% -$337K 0.84% 16
2015
Q3
$7.11M Sell
76,169
-18,026
-19% -$1.74M 0.82% 14
2015
Q2
$9.18M Buy
94,195
+21,139
+29% +$2.12M 0.9% 15
2015
Q1
$7.35M Sell
73,056
-7,354
-9% -$748K 1.02% 6
2014
Q4
$8.41M Buy
80,410
+2,197
+3% +$232K 1.13% 7
2014
Q3
$8.34M Sell
78,213
-13,034
-14% -$1.35M 1.14% 6
2014
Q2
$9.55M Sell
91,247
-9,270
-9% -$937K 1.26% 10
2014
Q1
$9.87M Buy
100,517
+74,009
+279% +$6.86M 1.5% 9
2013
Q4
$2.43M Buy
26,508
+1,304
+5% +$120K 0.39% 89
2013
Q3
$2.19M Buy
25,204
+12,239
+94% +$1.1M 0.46% 73
2013
Q2
$1.11M Buy
+12,965
New +$1.1M 0.29% 117

Other funds holding JNJ

Convergence Investment Partners's JNJ Position: Q2 2026 in Review

Convergence Investment Partners increased its Johnson & Johnson (JNJ) stake by 84% in Q2 2026, buying an estimated $3.19M and bringing the position to 29,971 shares worth $7.61M. The position accounts for 0.72% of the portfolio, ranked #37.

Convergence Investment Partners first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.87M in Q1 2014. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Convergence Investment Partners held 29,971 shares of Johnson & Johnson worth $7.61M as of Q2 2026.
  • Convergence Investment Partners bought 13,670 Johnson & Johnson shares in Q2 2026, an estimated $3.19M.
  • Johnson & Johnson made up 0.72% of Convergence Investment Partners's portfolio in Q2 2026, its #37 holding.
  • Convergence Investment Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Convergence Investment Partners's Johnson & Johnson position peaked at $9.87M in Q1 2014.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Convergence Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.